International Paper: Looking At The Russian Exposure

Mare Evidence Lab profile picture
Mare Evidence Lab


  • Ilim Group review and how it will affect IP earnings.
  • Short-term turbulence of energy price.
  • Positive long-term thesis.

Stoviglie monouso eco-compatibili e utensili da mangiare sul tavolo

Ilona Shorokhova/iStock via Getty Images

International Paper (NYSE:IP) was one of the first companies to report during the earnings season with the Q4 and FY report published at the end of January 2022. We already commented on the company's performance, to quickly recap, we were expecting a challenging first quarter due to labor and supply chain impacts, higher maintenance costs, and an ongoing energy price crisis. During the Q&A, IP was forecasting a raw material price normalization through the year and price increases to support margins beyond the first quarter. We rated the company with a neutral rating, highlighting the long-term investment thesis based on:

  1. The positive global trend in e-commerce;
  2. Plastic bans;
  3. ESG player with all the movements from Plastic to Paper.

Today, our main focus is to check the impact of one of the IP divisions, being a Joint Venture in Russia. According to IP, Ilim Group is the country's largest integrated manufacturer of pulp and paper and it is accounted as an equity investment.

During Q4, Ilim's JV earnings were positive for €66m compared to the previous year's quarter at $53m. Compared with the Q3 results, at operating level, Ilim's earnings decreased due to lower export sales prices in the softwood & hardwood pulp.


Ilim JV

At the year level, we can clearly see the positive performance of the Russian JV with positive results of $311m compared to the $48m posted in 2020.

ILIM JV earnings

Ilim JV earnings

In March, IP declared "its intention to explore strategic options, including the possible sale, of its 50% ownership interest in Ilim Group." Confirming also that it "has no intention to seek suspension of operations or initiate any liquidation or bankruptcy proceedings with respect to Ilim Group." As we can see below in the FY results presentation, management was still estimating a positive impact of $80m in equity earnings.

ILIM JV Guidance

Ilim JV Guidance

Looking at the last 5 years, we checked how the Ilim Group had influenced IP earnings. Currently, after the slight decrease in dividend due to the Sylvamo spin-off, IP is paying a total of $200m in dividends per quarter. The Ilim dividend is usually paid in the second quarter, and over the period taken into consideration, it had almost paid 1/4 of the IP dividend. Now we have two key questions: what's going on with pulp demand in Russia? And what's happening with the cash repatriation?

IP and ILIM cash flow from op.

IP and Ilim cash flow from op.

Even if the pulp demand in the region stays the same and no pulp is exported in Europe (Russia accounted for 8.6%), we know that companies such as Mondi (OTCPK:MONDF) (OTCPK:MONDY) and other important players are exiting the country and they no longer are producing. Relating to the future dividend payment, we don't have visibility on where the cash is deposited and if it can be transferred back.


We previously valued IP with a target price of $55 per share based on the average between:

  1. An 8.0x EV/EBITDA on our 12-month forward estimates,
  2. A DCF analysis in which we assume a 10% cost of equity and a terminal growth rate of 2%.

Aside from the Ilim Group operations and cash repatriation issue, we are pretty worried about the ongoing energy price effect. After adjusting our internal numbers and despite our long-term buy, we are lowering the target price to 50 dollars per share. Risks are equally important to the downside and we confirm our neutral rating.

If you are interested in our previous coverage on IP, please have a look at our recent publications:

  1. International Paper: Long Term Thesis Intact But Not Without Short Term Turbulence
  2. International Paper: COVID-19 Resiliency With Long-Term ESG Thesis

This article was written by

Mare Evidence Lab profile picture
Buy-side hedge professionals conducting fundamental, income oriented, long term analysis across sectors globally in developed markets. Please shoot us a message or leave a comment to discuss ideas.DISCLOSURE: All of our articles are a matter of opinion, informed as they might be, and must be treated as such. We take no responsibility for your investments but wish you best of luck.

Disclosure: I/we have a beneficial long position in the shares of IP either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (5)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.